Skip to main content
Clinical Trials/NCT00992953
NCT00992953
Completed
Phase 1

The Efficacy of Virtual Reality (VR) as an Adjunct Therapy for Acute Combat-related Post-Traumatic Stress Disorder (PTSD) in Non-Combatants

Office of Naval Research (ONR)2 sites in 1 country136 target enrollmentJanuary 2005

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Post-Traumatic Stress Disorder
Sponsor
Office of Naval Research (ONR)
Enrollment
136
Locations
2
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

It is proposed that using Virtual Reality as part of therapy will result in improvements in Post Traumatic Stress Disorder for Service Members with PTSD related to service in Iraq and/or Afghanistan.

Detailed Description

In the treatment development phase, participants will be enrolled in Virtual Reality therapy. The therapy will be based on principals of exposure therapy, but will also incorporate aspects of physiological monitoring, and cognitive restructuring. The therapy will be modified as indicated by clinical feedback, with a fixed protocol to be developed (with length of treatment and exact methods to be used to be determined). After a fixed protocol is agreed upon, the project will enter the randomized phase. In this portion, subjects will be randomly assigned to receive either the Virtual Reality Treatment, or sent back to a waiting list during which time they will receive usual treatment. Participants will be assessed to determine which treatment (VR or treatment as usual) results in the greatest improvements in PTSD, as measured by independent assessors using the Clinician Administered PTSD scale.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
October 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Office of Naval Research (ONR)

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with Post Traumatic Stress Disorder related to military service in Iraq or Afghanistan by a Military Medical Provider.
  • Willing and able to give informed consent to participate Willing to give up intoxicating substances on the days of therapy

Exclusion Criteria

  • Actively suicidal, homicidal, psychotic, or having a diagnosis of alcohol dependence that does not show signs of at least early remission

Outcomes

Primary Outcomes

Not specified

Study Sites (2)

Loading locations...

Similar Trials